About this trial
The goal of this observational study is to evaluate the neurodevelopment of children from the ARMED NEO cohort through the ASQ3 score.
Dose the multiexposure to medical devices plasticizers during the neonatal intensive care unit stay increases the risk of developing neurodevelopmental disorders ? Patients (their parents) will complète several questionnaires (ASQ3, environnemental survey, EPICES score) during a planned teleconsultation with the research team
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Live patient who participated in the ARMED NEO study, included at the Clermont-Ferrand or Lille hospitals
Patient whose holders of parental authority have expressed their non-opposition to their participation in the study
Disqualifiers
Patient whose guardians have expressed opposition to their participation in the study
Patient with no French speaking parent
patient
Trial population
Patients will be recruted in Clermont-Ferrand And Lille centers. They are ambulatory patients whose parents Will be contacted by phone by research team to plan, if they accept to participate, a teleconsultation
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
ASQ3® score translated into an overall numerical score corresponding to the total of 5 dimensions of the ASQ3 test.
ASQ3® score translated into an overall numerical score corresponding to the total of 5 dimensions of the ASQ3 test.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: